Treatment Patterns and Health Resource Utilization in Patients With Hepatocellular Carcinoma After Failure of Sorafenib in Real-World Setting in Taiwan
Year: 2022
Type: article
Study design: Observational Study
Source: Value in Health Regional Issues
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Eli Lilly and Company
OpenAlex ID: W4220802276
